Intrapulmonal nintedanib distribution in fibrotic interstitial lung disease patients: drug concentrations in lung explantates
Recruiting
- Conditions
- Interstitial lung disease
- Registration Number
- NL-OMON21428
- Lead Sponsor
- Erasmus MC dept. of Medical Oncology and dept. of Pulmonology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 10
Inclusion Criteria
Patients treated with nintedanib until lung transplantation
Exclusion Criteria
Unwilling to sign informed consent
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method